These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 39115384)

  • 1. Biologically based strategies for overcoming in vivo barriers with functional nano-delivery systems.
    Ahmadzadeh R; Taheri SA; Mohammadi N; Hjazi A; Menon SV; Kadhum WR; Kumar A; Shakir MN; Shayan FK; Shirinkami N
    J Biochem Mol Toxicol; 2024 Aug; 38(8):e23782. PubMed ID: 39115384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle mediated cancer immunotherapy.
    Gupta J; Safdari HA; Hoque M
    Semin Cancer Biol; 2021 Feb; 69():307-324. PubMed ID: 32259643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
    Liu Y; Zhou J; Li Q; Li L; Jia Y; Geng F; Zhou J; Yin T
    Adv Drug Deliv Rev; 2021 May; 172():80-103. PubMed ID: 33705874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
    Li M; Zhang F; Su Y; Zhou J; Wang W
    Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charge-Switchable nanoparticles to enhance tumor penetration and accumulation.
    Souri M; Golzaryan A; Soltani M
    Eur J Pharm Biopharm; 2024 Jun; 199():114310. PubMed ID: 38705311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
    Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
    J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
    Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
    Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
    Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
    Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal organic framework-based variable-size nanoparticles for tumor microenvironment-responsive drug delivery.
    Wang Y; Gao N; Li X; Ling G; Zhang P
    Drug Deliv Transl Res; 2024 Jul; 14(7):1737-1755. PubMed ID: 38329709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy.
    Wang Y; Deng T; Liu X; Fang X; Mo Y; Xie N; Nie G; Zhang B; Fan X
    Int J Nanomedicine; 2024; 19():6253-6277. PubMed ID: 38911497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System.
    Wang H; Bo W; Feng X; Zhang J; Li G; Chen Y
    Int J Nanomedicine; 2024; 19():5581-5603. PubMed ID: 38882543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy.
    Zhou Y; Chen X; Cao J; Gao H
    J Mater Chem B; 2020 Aug; 8(31):6765-6781. PubMed ID: 32315375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
    Jia M; Zhang D; Zhang C; Li C
    J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.
    Sun Y; Li Y; Shi S; Dong C
    Molecules; 2021 May; 26(9):. PubMed ID: 34062992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment.
    Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ
    Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple-negative breast cancer.
    Cao Y; Meng F; Cai T; Gao L; Lee J; Solomevich SO; Aharodnikau UE; Guo T; Lan M; Liu F; Li Q; Viktor T; Li D; Cai Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1950. PubMed ID: 38528388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.